TORONTO, May 21, 2013 /CNW/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and commercial
manufacturing services to the global pharmaceutical industry, announced
today that Antonella Mancuso, President, Global Commercial Operations
and Chief Manufacturing Officer, notified the company that she plans to
resign from her positions with the company and its subsidiaries,
effective July 10, 2013.
About Patheon Inc.
Patheon Inc. (TSX: PTI) is a leading provider of contract development
and commercial manufacturing services to the global pharmaceutical
industry for a full array of solid and sterile dosage forms. Through
the company's recent acquisition of Banner Pharmacaps - a market leader
in soft gelatin capsule technology - Patheon now also includes a
proprietary products and technology business.
Patheon provides the highest quality products and services to
approximately 300 of the world's leading pharmaceutical and
biotechnology companies. The company's integrated network consists of
18 locations, including 14 commercial contract manufacturing facilities
and 12 development centers across North America and Europe. Patheon
enables customer products to be launched with confidence anywhere in
the world. For more information visit www.patheon.com.
SOURCE Patheon Inc
SOURCE: Patheon Inc.
For further information:
Senior Representative, Corporate Communications & Investor Relations
919 226 3200